Publicacións (101) Publicacións de Miguel Abal Posada

2024

  1. Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities

    Acta Biomaterialia, Vol. 173, pp. 261-282

  2. Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

    Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1

2023

  1. Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Extracellular Vesicles’ Genetic Cargo as Noninvasive Biomarkers in Cancer: A Pilot Study Using ExoGAG Technology

    Biomedicines, Vol. 11, Núm. 2

  3. Insights into Healthcare Professionals’ Perceptions and Attitudes toward Nanotechnological Device Application: What Is the Current Situation in Glioblastoma Research?

    Biomedicines, Vol. 11, Núm. 7

  4. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

2022

  1. Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands

    Biomedicine and Pharmacotherapy, Vol. 153

  2. Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  3. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

  4. Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment

    Cancers, Vol. 14, Núm. 6

2021

  1. Dissecting breast cancer circulating tumor cells competence via modelling metastasis in zebrafish

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

  2. Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis

    Scientific Reports, Vol. 11, Núm. 1

  3. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

    Gynecologic Oncology, Vol. 161, Núm. 3, pp. 681-686

  4. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas

    Biomedicine and Pharmacotherapy, Vol. 140

2020

  1. Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer

    DMM Disease Models and Mechanisms, Vol. 13, Núm. 6

  2. Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges

    Frontiers in Oncology, Vol. 10

  3. Endometrial Tumour Microenvironment

    Advances in Experimental Medicine and Biology (Springer), pp. 215-225

  4. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  5. Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14

2019

  1. Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer

    Cancers, Vol. 11, Núm. 12